PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 14: Articles 6501-7000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.
  2. Desogestrel contraceptives: the perfect pill for lipids? [Les contraceptifs a base de desogestrel: la pilule parfaite pour les lipides?]
  3. Desogestrel, gestodene contraceptives may carry greater thromboembolic risk.
  4. The determinants of contraceptive innovation: a case-control study of family planning acceptance in a traditional African society.
  5. Determinants of contraceptive use in Morocco: stopping behaviour in traditional populations.
  6. Determinants of contraceptive use: national population-based studies in various West European countries.
  7. Determinants of marital fertility in Pakistan: the impact of education, work and family planning.
  8. Determinants of oral contraceptive use by Italian women, 1991-1993. [Determinanti dell'uso dei contraccettivi orali nelle donne italiane, 1991-1993.]
  9. Developing health and family planning materials for low-literate audiences: a guide. Revised ed.
  10. Development and utilization of a modified counselling and referral system in the promotion of family planning (FP) and reproductive health (RH) in Iloilo City.
  11. Development of USAID, Bangladesh Health and Family Planning Project, October 1-24, 1996, November 11-14, 1996.
  12. Diabetes and oral contraception. Lipoprotein metabolism in women with insulin dependent diabetes mellitus using oral contraceptives. [Diabetesregulering og p-piller. Lipoproteinomsoetning hos kvinder med insulinkroevende diabetes mellitus v p-pillebehandling.]
  13. A diagnostic OR study to increase contraceptive prevalence rate (CPR) in Davao City.
  14. A diagnostic study to decrease the number of drop-outs among MWRAs who are practicing family planning in the province of Tarlac.
  15. Differences between husbands and wives in attitudes toward contraceptive use and fertility preferences.
  16. Dihydroxyprogesterone acetophenide 150 mg plus estradiol enantate 10 mg as monthly injectable contraceptives.
  17. Directive counseling on long-acting contraception.
  18. Directory of hormonal contraceptives 1996. 3rd ed. [Repertoire des contraceptifs hormonaux 1996. 3e edition. Guia de anticonceptivos hormonales 1996. 3a edicion.]
  19. A discussion guide for trainers: using the KAYNAK video to improve interpersonal communication between family planning service providers and clients. [Danismanlik egitiminde "KAYNAK" video programi kullanim rehberi.]
  20. Disparities in access to family planning services in Jamaica.
  21. District court bars exclusion of Planned Parenthood from Missouri state funding.
  22. Do antibiotics decrease effectiveness of oral contraceptives?
  23. Do different family planning funding mechanisms produce different results?
  24. Do family planning programs affect reproductive preferences?
  25. Do family planning programs enhance children's health?
  26. Do teenagers consult GPs for contraceptive advice? [letter]
  27. Does progesterone increase HIV risk? Contraceptive update.
  28. Does the use of contraception reduce the risk of pregnancy-induced hypertension?
  29. Donor support for contraceptive commodities.
  30. Down syndrome and natural family planning [letter]
  31. Dynamics of contraceptive practice amongst urban Indian women.
  32. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
  33. ECPs, emergency contraceptive pills: service delivery guidelines.
  34. Editorial: family planning, sexually transmitted diseases, and the prevention of AIDS -- divided we fail? [editorial]
  35. Education, fertility desires, and the perceived cost of contraception.
  36. The effect of birth control methods on sexually transmitted disease / HIV risk.
  37. The effect of female family planning workers on the use of modern contraception in Bangladesh.
  38. The effect of levenogesterol (Norplant) contraception on coagulation as measured by antithrombin-III levels.
  39. Effect of low dose oral contraceptives on exercise performance.
  40. The effect of Norplant implants training on increasing access to family planning services: the Senegal and Mali experiences. FCA-24.
  41. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
  42. Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle.
  43. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
  44. The effect on serum lipids and lipoproteins of three combined oral contraceptives containing norgestimate, gestodene and desogestrel.
  45. Effectiveness of breast self-examination prompts on oral contraceptive packaging.
  46. The effectiveness of the Yuzpe regimen of emergency contraception.
  47. The effects of a low-dose gestodene-containing oral contraceptive on endometrial histology in healthy women.
  48. The effects of a new low-dose combined oral contraceptive containing levonorgestrel on ovarian activity.
  49. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
  50. The effects of family planning on marital disruption in Malaysia.
  51. The effects of hormones on male sexuality. Findings from clinical trials on male contraception.
  52. The effects of maternal-child nutrition program cash subsidies on contraceptive use in rural Honduras.
  53. Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle.
  54. Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. World Health Organization Task Force on Methods for the Regulation of Male Fertility.
  55. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
  56. Elements of family planning in population education programmes.
  57. Emergency contraception -- a prescription for change.
  58. Emergency contraception -- over the counter? [letter]
  59. Emergency contraception hot line launched.
  60. Emergency Contraception Hotline, 1-800-584-9911. Hotline update No. 1.
  61. Emergency contraception in the curriculum?
  62. Emergency contraception in the United Kingdom and the Netherlands.
  63. Emergency contraception using progestogen alone.
  64. Emergency contraception with mifepristone and anordrin.
  65. Emergency contraception, a method whose time has come: an update.
  66. Emergency contraception, weekends and bank holidays: improving access through cooperation between hospital and community based services.
  67. Emergency contraception: safe and cost-effective contraceptive first aid.
  68. Emergency contraception: the International Planned Parenthood Federation's experience.
  69. Emergency contraceptive pills. A resource packet for health care providers and programme managers.
  70. Emergency contraceptive pills: a survey of use and experiences at college health centers in the mid-Atlantic United States.
  71. Emergency contraceptive pills: safe and effective but not widely used.
  72. Emergency hormonal contraception usage in genitourinary medicine clinic attenders.
  73. Emergency postcoital contraception.
  74. Employer-based family planning services in Zimbabwe. A summary.
  75. Endangered: U.S. aid for family planning overseas.
  76. Endangered: U.S. aid for family planning overseas. IPPF / WHR reports.
  77. The entertainment media as "sex educators?" And, other ways teens learn about sex, contraception, STDs, and AIDS. Q and A.
  78. Epidemiology of non-acceptance of permanent method of contraception by women in northern India.
  79. Estimating contraceptive needs from trends in method mix in developing countries.
  80. Ethinyl oestradiol plus dl-norgestrel or levonorgestrel in the Yuzpe method for post-coital contraception: results of an observational study.
  81. Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system.
  82. European Contraceptive Congress 12-16/7/1996. Barcelona.
  83. Evaluating family planning programs with adaptations for reproductive health.
  84. Evaluating information-education-communication (IEC) programs for family planning and reproductive health. Final report of the IEC working group.
  85. Evaluating rural Bangladeshi women's perspectives of quality in family planning services.
  86. Evaluating the impact of family planning programmes.
  87. An evaluation of a family planning intervention.
  88. Evaluation of sex and contraception education at the contraception clinic in Odense, Denmark. [Evaluering af seksual- og praeventionsundervisningen pa antikonceptionsklinikken v Odense.]
  89. Evaluation Survey for Maternal and Child Health and Family Planning in the 11 Provinces, 1995. Summary report.
  90. Even as new options emerge, gynecologists urge women to find older contraceptives user-friendly.
  91. Evidence for interpopulation variation in normal ovarian function and consequences for hormonal contraception.
  92. Examining male roles in population policies and family planning programs.
  93. Expanding contraceptive choice: findings from Zambia.
  94. An experimental study on the organization and mobilization of satisfied male and female FP users as program communicators in the promotion of family planning practice and reproductive health in Iloilo province.
  95. Expert Consultation on Reproductive Health and Family Planning: Directions for UNFPA Assistance, UNFPA, New York, 8-9 December 1994.
  96. Extending family planning services to unreached population groups.
  97. Face to face: training family planning counselors in China.
  98. Factor V Leiden and third-generation oral contraceptives [letter]
  99. Factor V Leiden and third-generation oral contraceptives. Authors' reply [letter]
  100. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
  101. Factors affecting contraceptive use in Pakistan.
  102. Factors affecting the consistent use of barrier methods of contraception.
  103. Factors affecting use of contraception in Matlab, Bangladesh.
  104. Factors influencing choice of a contraceptive and the reasons for its discontinuation.
  105. Factors predicting marriage and contraceptive use among adolescents in Kenya.
  106. Factors related to choosing oral contraception at age 15.
  107. The family building life course and contraceptive use: Nang Rong, Thailand.
  108. The family planning / reproductive health program: recent developments.
  109. Family planning among rural Moslem women in Israel.
  110. Family planning and audit. National Coordinating Unit for Clinical Audit in Family Planning. Summary of workshops of the first annual conference held at Royal College of Obstetricians and Gynaecologists: July 14, 1995.
  111. Family planning and demographic yearbook, 1995.
  112. Family planning and lifestyles in Germany.
  113. Family planning and marital disruption in Malaysia.
  114. Family planning and men: DHS surveys of men in developing countries.
  115. Family planning and prosperous family data sheet 1996. [Lembaran data. Keluarga berencana dan keluarga sejahtera 1996.]
  116. Family planning and reproductive health in selected member states of the Economic Commission for Europe.
  117. Family planning and reproductive health in Zambia today.
  118. Family planning associations vital to supervision of programme implementation.
  119. The family planning attitudes and experiences of low-income women.
  120. Family planning centers in France: health resource centers for adolescents and young adults. [Les centres de planification familiale en France: structures de recours aux soins pour adolescents et les jeunes.]
  121. Family planning clinic services in the United States, 1994.
  122. Family planning communication survey (findings of FGDs). [Draft report]
  123. Family planning continuation among MOH defaulters in Ghana: draft preliminary report.
  124. Family planning covers 24.6 million fertile couples.
  125. Family planning facilities in rural Tanzania: his and her perceptions of time and distance.
  126. Family planning for the underserved: an IPPF perspective.
  127. Family planning in Cambodia.
  128. Family planning in Indonesia: a source of far-reaching controversy. A rejoinder to Breman and White.
  129. Family planning in the Solomon Islands [letter]
  130. Family planning in Vietnam -- women's experiences and dilemma: a community study from the Red River delta.
  131. Family planning is acceptable. Muslim religion does shed light on all the problems of humankind and leads the people to clarity of mind, satisfied conscience and happiness.
  132. Family planning management of the floating population in Xi'an city.
  133. Family planning method usage in a study of women who came for pregnancy termination: (southwestern Nigeria)
  134. Family planning methodologies.
  135. Family planning methods for men in developing countries with special reference to vasectomy efforts in Pakistan.
  136. Family planning policies and programmes in countries of Africa.
  137. Family planning policies and programmes: lessons learned.
  138. Family planning practices and attitudes in Tanzania: the case of artisanal fisherman in Bagamoyo district.
  139. Family planning practices before and after childbirth in Lusaka, Zambia.
  140. Family planning program impact: evidence from six developing countries.
  141. Family planning program performance in Bangladesh: a method-specific overview of the past decade and future prospects.
  142. The family planning programme and contraceptive use in India: a marketing perspective.
  143. Family planning programmes in Latin America: current situation and new challenges.
  144. Family planning programs and other interventions to assist women: their impact on demographic change and on the status of women.
  145. Family planning programs in Asia: approaching a half-century of effort.
  146. Family planning programs in Muslim countries: successful cases. [Programi za planiranje porodice u muslimanskim zemljama: uspesni primeri.]
  147. Family planning programs: efforts and results, 1972-94.
  148. Family planning provision in genitourinary medicine clinics: a quiet revolution.
  149. Family planning reproductive health: the neglected factor.
  150. Family planning requirements in the adult congenital heart disease clinic.
  151. Family planning revolution in Thailand: lessons for other countries.
  152. Family planning services and unreached population groups.
  153. Family planning services in Ethiopia: problems and prospects.
  154. The Family Planning Training Institute looks at the impact of its work. Case scenarios for training and group discussion.
  155. Family Planning Training Programme of the Indian Medical Association. [Baseline survey of IMA members regarding knowledge, attitude and delivery of FP services in UP]
  156. Family planning using the ecologic breast feeding method [letter]
  157. Family planning, health and family well-being.
  158. Family planning, sexually transmitted diseases and AIDS.
  159. Family planning, sexually transmitted diseases and AIDS.
  160. Family planning. [Planificacion familiar.]
  161. Family planning. [Planification familiale.]
  162. Family planning. [Planification familiale.]
  163. Family planning: an international perspective.
  164. Family planning: no one stops Fujimori. [Planificacion familiar: nadie detiene a Fujimori.]
  165. Farmers' paintings promote family planning.
  166. FDA finds emergency postcoital contraception safe and effective.
  167. FDA panels probe efficacy of barrier contraceptives.
  168. Feasibility of a telephone follow-up on use of emergency contraceptive pills in a college health center.
  169. Female adolescent contraceptive use or nonuse at first and most recent coitus.
  170. Female health foundation launched to educate women. Contraception (STDs)
  171. Fertility and contraceptive use in Tamil Nadu, Andhra Pradesh, and Uttar Pradesh.
  172. Fertility and family planning behaviour in Indian society.
  173. Fertility and family planning in Vietnam: evidence from the 1994 Inter-censal Demographic Survey.
  174. Fertility awareness and natural family planning. Opinion.
  175. Fertility behaviour and contraceptive use in Kenya: findings from a male survey.
  176. Fertility control by emergency contraception.
  177. Fertility differentials according to females' education, employment and family planning adoption in rural Bangladesh.
  178. Fertility has fallen in Zimbabwe, reflecting rising contraceptive use and desire for smaller families.
  179. The fertility transition in Cuba and the Federal Republic of Korea: the impact of organised family planning.
  180. Fertility, contraception and poverty in Peru. [Fecundidad, anticoncepcion y pobreza en el Peru.]
  181. Fetal Candida infection associated with an intrauterine contraceptive device.
  182. The fiction of an ideal hormonal contraceptive.
  183. Field trial of Billings ovulation method of natural family planning.
  184. Final report to the Ford Foundation: Men's Involvement in Family Planning: Qualitative Research in Three Provinces. Grant Number 930-0343: 12/1/92 - 5/31-94. Grant Number 930-0343-1: 3/1/95 - 2/29/96.
  185. Final report. Contributions of Demand Mobilization and Contraceptive Availability to Increased Contraceptive Prevalence: Issues for Replication: The Gambia. Save the Children Federation, The Gambia Field Office. Funded by the Population Council Contract No. CI95.16A, April 1, 1995 -September 30, 1996.
  186. Final report. Operations Research and Technical Cooperation in Family Planning and Maternal-Child Health in Latin America and the Caribbean, USAID Contract No. DPE-3030-Z-00-9019-00, 1989-1995. [Informe final. Investigación Operativa y Cooperación Técnica en Planificación Familiar y Salud Materno-Infantil en América Latina y el Caribe, USAID Contrato DPE-3030-Z-00-9019-00, 1989-1995.]
  187. Final report. Proceedings of the National Seminar on the Village Based Family Planning Workers Scheme, Islamabad, Pakistan, June 4-5, 1996.
  188. Final report. Proceedings of the Provincial Seminar on the Village Based Family Planning Workers Scheme, 30-31 July, 1996, Peshawar.
  189. Final report. Proceedings of the Provincial Seminars / Workshops on the Village Based Family Planning Workers Scheme, 16-18 July, 1996, Karachi, 21-23 July, 1996, Hyderabad.
  190. Final report. Qualitative study on women who discontinue use of the injectable contraceptive, Depo-Provera. [Informe final. Estudio cualitativo en mujeres descontinuadoras de inyectable Depo-Provera.]
  191. Final report. Second situation analysis of the family planning program in Burkina Faso, March 1995 - July 1996. [Rapport final. Deuxieme analyse situationnelle du programme de planification familiale au Burkina Faso, Mars 1995 -Juillet 1996.]
  192. Final report: Operations Research and Technical Assistance in Family Planning and Maternal-Child Health in Latin America and the Caribbean, USAID Contract DPE-3030-Z-00-9019-00 1989-1995. INOPAL II project. [Informe final: Investigación operativa y asistencia técnica en planificación familiar y salud materno infantil en América Latina y el Caribe, Agencia Estadounidense para el Desarrollo Internacional (USAID), Contrato DPE-3030-Z-00-9019-00 1989-1995. Proyecto INOPAL (Investigación Operativa y Asistencia Técnica en Planificación Familiar y Salud Reproductiva en América Latina y el Caribe) II.]
  193. Findings from phase I of the Navrongo Community Health and Family Planning Project.
  194. Findings from the Sub-Saharan Africa Urban Family Planning Study. Overview of studies conducted in Blantyre, Malawi, Bulawayo, Zimbabwe, Mombasa, Kenya.
  195. Follow-up of intrauterine contraceptive devices (IUDS)
  196. Forecast of public sector budget requirements for contraceptive commodities in Turkey: 1995-1999. June 1996 update.
  197. From control policy to comprehensive family planning: success stories from Finland.
  198. From family planning to reproductive health. What does it mean? [editorial]
  199. From family planning to reproductive health: a program manager's perspective.
  200. Funding for family planning services allows open access [editorial]
  201. Future contraceptive requirements and logistics management needs.
  202. Future contraceptive requirements: the potential role of local production in meeting the needs of developing countries.
  203. The future of oral contraceptives: research priorities.
  204. Gender awareness in family planning. Putting both men and women in the equation.
  205. Gender composition of surviving children and contraceptive use in Bangladesh.
  206. Gender perspective in family planning programmes.
  207. GnRH agonist for postpartum contraception: biochemical, hormonal and endometrial effects.
  208. Great achievements for China's population and family planning programmes between 1991-1995.
  209. Guidelines for clinical procedures in family planning: a reference for trainers. Appendix 11: Infection prevention in FP / MCH clinics. Revised ed.
  210. Guidelines for clinical procedures in family planning: a reference for trainers. Chapter 6: Progestin-only injectable contraceptives. Revised ed.
  211. The guru of family planning retires.
  212. Handbook of contraception and family planning.
  213. Hanoi hosts family planning meet.
  214. Health education at family planning clinics: strategies for improving information about contraception and sexually transmitted diseases for low-income women.
  215. Henan intensifies family planning implementation.
  216. Hepatocellular carcinoma in long-term oral contraceptive use.
  217. Hillary Clinton takes up defense of U.S. aid for family planning overseas.
  218. History and efficacy of emergency contraception: beyond Coca-Cola.
  219. HIV / STD prevention update. Some women still confuse contraception and pregnancy prevention with disease prevention.
  220. Hormonal contraception and HIV.
  221. Hormonal contraception and lactation.
  222. Hormonal contraception for men [letter]
  223. Hormonal contraception for men? [editorial]
  224. Hormonal contraception: a cost benefit analysis [editorial]
  225. Hormonal contraceptives and the risk of sexually transmitted diseases (STDs). A question and answer sheet.
  226. Hormonal contraceptives and the risk of STDs.

     

  227. Hospital based out-of-hours emergency contraception [letter]
  228. Hospital based out-of-hours emergency contraception [letter]
  229. Hospital based out-of-hours services for emergency contraception [letter]
  230. How effective are contraceptives? The determination and measurement of pregnancy rates.
  231. How to counsel in family planning? An interpersonal communication challenge. [Como aconsejar en planificacion familiar? Un reto de comunicacion interpersonal.]
  232. The human right to family planning and sexual and reproductive health.
  233. The husband's role in family planning.
  234. Husband-wife roles as a correlate of contraceptive and fertility behaviour.
  235. ICPD and family planning associations.
  236. Immediate postpartum insertion of the Norplant contraceptive device.
  237. Immediate postplacental insertion of Gyne-T 380 and Gyne-T 380 Postpartum intrauterine contraceptive devices: randomized study.
  238. Immunization against exon 1 decapeptides from the lutropin / choriogonadotropin receptor or the follitropin receptor as potential male contraceptive.
  239. The impact of an unplanned pregnancy and termination on intended future contraception: implications for reproductive health promotion.
  240. The impact of media campaigns and interpersonal communication on contraceptive use in Nigeria.
  241. The impact of official family planning programs on transition to motherhood: a case study of Shifang County.
  242. Impact of patient counseling on acceptance of the levonorgestrel implant contraceptive in the United Kingdom.
  243. The impact of postpartum redundant use of contraception on contraceptive failure rates.
  244. Impact of publicly funded contraceptive services on unintended pregnancies and implications for Medicaid expenditures.
  245. The impact of publicly funded family planning.
  246. Impact of the family planning campaign, Peru, 1992-1995. Preliminary report.
  247. The impending demise of community family planning clinics? [letter]
  248. The implementation of development of family planning and prosperous family information education communication (IEC) intervention and strategy in the river stream area of South Kalimantan, Indonesia, 1994/1995. Report.
  249. Implications of smoking and oral contraceptive use.
  250. Improvements in family planning services in Tanzania: a report based on the 1991 and 1994 Demographic Health Surveys.
  251. Improving access to quality care in family planning: medical eligibility criteria for initiating and continuing use of contraceptive methods.
  252. Improving quality of care in family planning and reproductive health programmes.
  253. Improving quality of care in family planning: how far have we come?
  254. Improving quality of care: a status report. Family planning.
  255. Improving the use of contraceptives: the challenge continues.
  256. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy)
  257. An increase in the use of contraceptives. Reaching out: Paraguay.
  258. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
  259. Increased levels of several lysosomal enzymes in sera from women using oral contraceptives.
  260. Increasing male responsibility in family planning.
  261. India situation analysis: identifying service gaps. Family planning in Uttar Pradesh.
  262. Indicators of family planning needs.
  263. Indigenous systems of medicine and homeopathy practitioners' (ISM and HPs') training project in non-clinical methods of family planning. Training Manual. Draft.
  264. Induced abortion and contraceptive use in Russia; state of the art and need for a micro-approach.
  265. Induced abortions in relation to preceding contraceptive methods. [Provokerede aborter sat v relation til brugen af praeventive midler.]
  266. Influence of family head's reproductive behaviour on the use of modern contraceptive methods by other members of the family in rural Bangladesh.
  267. Information records on contraceptives. A tool for advisors in logistics. [Hojas informativas sobre anticonceptivos. Una herramienta para asesores de logistica.]
  268. Information, advice and counselling: a study of non-clinical aspects of the family planning services.
  269. The initiation of adolescent sexual and contraceptive behavior during changing times.
  270. Injectable contraceptives introduced in Viet Nam on a trial basis.
  271. Integrated approach to family planning: Minister Peng Peiyun stresses transitions.
  272. Integration of family planning with poverty alleviation.
  273. Integration of GTI management with family planning service delivery: lessons learned in Zimbabwe.
  274. Integration of poverty alleviation with family planning: an interview with SFPC Vice Minister Yang Kuifu.
  275. Integration of RTI care into existing family planning services.
  276. Intention to use contraceptives and subsequent contraceptive behavior in Morocco.
  277. Inter-spouse communication, contraceptive use and family size: relationship examined in Bihar and Tamil Nadu.
  278. International aid to population and family planning in Vietnam.
  279. International family planning: charting a new course.
  280. International Planned Parenthood head visits Pathfinder.
  281. Interpersonal communication and family planning counseling.
  282. Intrauterine contraception in nulligravid vs parous women.
  283. Intrauterine contraception in the U.S.: a current perspective. Conference proceedings.
  284. Intrauterine copper contraceptive implant. [Implant intra-uterin contraceptif au cuivre (ICIU)]
  285. Introducing emergency contraceptive services: communications strategies and the role of women's health advocates.
  286. Introducing new contraceptive methods: the three-stage research approach.
  287. The introduction of a new contraceptive; two years experience with Norplant.
  288. Introduction of contraceptive technology: lessons from the use of Norplant in Indonesia.
  289. Involving men in family planning: the Zimbabwe Male Motivation and Family Planning Method Expansion Project, 1993-1994.
  290. IOM report calls for research into new contraceptives.
  291. Is it necessary to be concerned about coagulation disorders in women using combined oral contraceptives? [Je treba se obavat poruch koagulace u zen uzivajicich preparaty oralni kombinovane kontracepce?]
  292. Is oral contraceptive associated with genital warts?
  293. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
  294. Islam is for family planning. Husbands and wives can stop pregnancy for medical, psychological, social and/or financial reasons.
  295. It's a mega dose of hormones, isn't it? Why women may be reluctant to use emergency contraception.
  296. IUDs and oral contraceptives: the most used methods in the world. [Dispositivos intrauterinos y pildora: usados mas popularmente en el mundo.]
  297. IUSSP activities: Committee on Fertility and Family Planning. Implications of the International Conference on Population and Development (ICPD) Programme of Action for the IUSSP.
  298. The Kaiser Family Foundation National Survey on Public Perceptions about Contraception. Chart pack.
  299. The Kaiser Survey on Public Perceptions about Contraception. Questionnaire and top lines.
  300. Key issues in family planning, health and family well-being in the 1990s and beyond.
  301. Knowledge and attitudes about reproductive health and HIV / AIDS among family planning clients. [Connaissances et attitudes en matière de santé reproductive et de VIH/SIDA chez les clients des structures de planning familial.]
  302. Knowledge of emergency contraception amongst men and women in the general population and women seeking an abortion.
  303. Knowledge, attitude, and practice of male contraception in Upper Egypt and Cairo, 1991.
  304. Laboratory criteria for menopause in women using oral contraceptives.
  305. Lack of interaction between orlistat and oral contraceptives.
  306. Lactational amenorrhea method for family planning.
  307. Lactational amenorrhoea and family planning.
  308. Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide.
  309. Learning about sexuality through family planning counseling sessions in Indonesia.
  310. Learning in social networks: contraceptive choice and other technological dynamics.
  311. A legacy of humanistic family planning. Chojiro Kunii.
  312. Legal, ethical and regulatory aspects of introducing emergency contraception in the Philippines.
  313. Lessons learned from research, evaluation and analysis studies of the Private Sector Family Planning Project.
  314. Lessons learned: Azerbaijan. Introducing family planning education. Two approaches: women's groups and outreach workers.
  315. Lessons learned: Cote d'Ivoire and Ghana. Family planning and AIDS program: training, evaluation and transfer to a local NGO.
  316. Levels and trends of contraceptive use as assessed in 1994.
  317. Levonorgestrel capsules: a big leap forward in intrauterine contraception (letter) [De levonorgestrel-capsule: een grote sprong voorwaarts in de intra-uteriene anticonceptie.]
  318. Levonorgestrel contraceptive implants. Reality and controversies concerning a current contraceptive method. [Implantes anticonceptivos de levonorgestrel. Realidades y controversias de un metodo anticonceptivo actual.]
  319. Levonorgestrel contraceptive implants. Reality and controversy of a current contraceptive method. [Implantes anticonceptivos de levonorgestrel. Realidades y controversias de un metodo anticonceptivo actual.]
  320. The life of family planning pioneer, Constance Goh: a point of light.
  321. Literacy and contraception: exploring the link.
  322. Little risk of stroke for healthy young women using oral contraceptives.
  323. Logistics guidelines for family planning programs. [Guias logisticas para programas de planificacion familiar.]
  324. Long-acting contraceptive options.
  325. Long-acting progestogen-only contraception.
  326. The long-term demographic role of community-based family planning in rural Bangladesh.
  327. Long-term use of three-monthly injectable contraceptive DMPA not linked to breast cancer.
  328. Low-dose combined estrogen-progestin oral contraceptives and pulmonary embolism: a case report. [Estroprogestinici orali a basso dosaggio ed embolia polmonare: descrizione di un caso clinico.]
  329. Low-dose oral contraceptives and stroke [editorial]
  330. Luteinizing hormone releasing hormone agonist for postpartum contraception.
  331. Making oral contraceptives available over-the-counter [letter]
  332. Making space for young men in family planning clinics.
  333. Male contraception.
  334. Male contraception.
  335. Male contraception. Withdrawal: a time-honoured but risky method?
  336. Male contraceptive knowledge and practice: what do we know?
  337. A male contraceptive pill [letter]
  338. Male contraceptive pill to start trial in Brazil.
  339. Male hormonal contraception. What prospects exist and how acceptable are they?
  340. Male involvement and contraceptive methods for men: present and future.
  341. Male involvement in family planning.
  342. Male involvement in family planning. A review of the literature and selected program initiatives in Africa. [Participation des hommes a la planification familiale. Revue de la litterature et analyse d'initiatives choisies de programmes en Afrique.]
  343. Male involvement in family planning: a challenge for the national programme workshop. Final report.
  344. Male involvement: a challenge for the Bangladesh national family planning program.
  345. Male needs and responsibilities in family planning and reproductive health.
  346. Male participation in reproductive health, including family planning and sexual health. [Participacion masculina en salud reproductiva, incluyendo planificacion de la familia y la salud sexual.]
  347. Management strategies for improving family planning services. The Family Planning Manager compendium.
  348. Many South African women found to have limited contraceptive choice.
  349. Market-based services: strategic role in family planning service expansion.
  350. Mass media influences on contraceptive behavior and reproductive preferences.
  351. Mass-media-generated interpersonal communication as sources of information about family planning.
  352. Maternal and child health / family planning and abortion in Madagascar.
  353. Maternal health and family planning in Bolivia, Ecuador, Peru and Colombia. Survey findings and program implications for Plan International.
  354. A matter of planning the family.
  355. Measuring contraceptive effectiveness: a conceptual framework.
  356. Measuring the achievements and costs of reproductive health programs. Report of a meeting of the Working Group on Reproductive Health and Family Planning, the World Bank, June 24-25, 1996.
  357. Mechanism of action of NIM-76: a novel vaginal contraceptive from neem oil.
  358. Medical eligibility criteria for contraceptive use developed.
  359. Men and family planning in Africa.
  360. Men and family planning: focus on Egypt.
  361. Men's and women's views of contraception: a study in the Philippines.
  362. Men's fertility, contraceptive use, and reproductive preferences.
  363. Men's involvement in family planning.
  364. Men's knowledge, attitudes and practices with regard to family planning.
  365. Men's perceptions of their roles and responsibilities regarding sex, contraception and childrearing.
  366. Men's role in reproductive health: family planning is a family affair.
  367. Men, couples, and family planning: a retrospective look.
  368. Metabolic effects of oral contraceptives: fact vs. fiction.
  369. Methodologic commentary: why pregnant adolescents say they did not use contraceptives prior to conception.
  370. Mifepristone: a potential contraceptive.
  371. Millions of couples to have choice of injectable contraceptive.
  372. The missing forgotten intrauterine contraceptive device.
  373. Mobilizing Gecekondu residents to seek family planning services. Preliminary proposal for the U.S. Embassy in Turkey.
  374. Monitoring and evaluating reproductive health / family planning programs.
  375. Monitoring family planning programs 1996. [Wallchart]
  376. A multicenter European survey of the attitudes to contraception in women at high risk or with established cardiovascular disease.
  377. Muslims' low practice of family planning. India. Low levels of education, particularly among women, is one of the major reasons behind high fertility rates.
  378. National AIDS Commission to formulate AIDS policy in Turkey established with Family Planning Association of Turkey leadership.
  379. The national family planning movement through charts and pictures. 1995/1996. [Gerakan keluarga berencana nasional dalam grafik dan gambar.]
  380. Natural family planning -- better prospect of contraception.
  381. Natural family planning and Down syndrome -- matching and confounding in a case control study [letter]
  382. Natural family planning.
  383. Navajo Nation expands family planning services.
  384. The need to assess family planning programs in a manner consistent with the reproductive health approach.
  385. Negative reports on oral contraceptives -- increased number of induced abortions. [Negativ omtale av p-piller -- okning av antall svangerskapsavbrudd.]
  386. Nepal Family Planning Communication Survey, 1994. Key findings report, Vol. I. Four district baseline survey.
  387. Nepal. Final report: Development of the Comprehensive Family Planning Video (COFP). Fixed price contract between the Johns Hopkins University Population Communication Services and Dristi Productions, PVT., LTD, December 10, 1994 - June 30, 1995, AS-NEP-09.
  388. A new and promising agenda. Substantial family planning cooperation among countries and regions under the Islamic culture and religion will be developed.
  389. New birth control options.
  390. New contraceptive option for breast-feeding mothers. Micronor labeling modified.
  391. New directions in the Integrated Family Planning and Maternal Health Program (IFPMHP)
  392. New discoveries on oral contraceptives and risk of breast cancer. International data show a moderate increase in risk. [Nya ron om p-piller och brostcancerrisk. Internationella data pavisar mycket blygsam riskokning.]
  393. New generation of progestins may raise oral contraceptive users' risk of blood clots.
  394. New generation of progestins may raise oral contraceptive users' risk of blood clots.
  395. New generation oral contraceptives and venous thromboembolic diseases: unexpected results] [Contraceptifs oraux de nouvelle generation et maladies thromboemboliques veineuses: des resultats inattendus]]
  396. New hormonal methods of contraception.

     

  397. New methods of mathematical analysis for studies of intrauterine contraception.
  398. A new perspective on the definition and measurement of unmet need for contraception.
  399. New Programme research on the safety of oral contraceptive pills.
  400. New shift to family planning programme.
  401. Newsroom guide to abortion and family planning. 2nd ed.
  402. NFP offers user-control, but requires discipline. Contraceptive update.
  403. The Nigeria family planning facility census: implications for social marketing.
  404. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
  405. No room to assume in birth control.
  406. Non-contraceptive benefits of oral contraceptives.
  407. Non-contraceptive health benefits of oral contraception. Survey of women's attitudes and perceptions about their health care providers and non-contraceptive health benefits of oral contraception. Top-line results of a survey of 250 women who are smokers and users of oral contraceptives.
  408. Normative processes in reproductive health: already there are contraception protocols for five prevalent diseases. [Proceso normativo en salud reproductiva: ya se tienen protocolos de anticoncepcion en cinco enfermedades prevalentes.]
  409. Norplant subdermal contraceptive system: experience in Taiwan.
  410. Norplant, subdermal contraceptive implant. [Norplant, implante anticonceptivo subdermico.]
  411. Not contradicting the religion. Islam has been putting on emphasis on family planning for 14 centuries.
  412. Nuptiality, fertility, use of contraception, and family policies in Uzbekistan.
  413. Nurse only family planning clinics.
  414. Nurses who dispense post-coital contraception.
  415. NWFP. Follow-up of recommendations of the Workshops on Village Based Family Planning Workers Quality Improvement.
  416. OCs provide emergency contraception option.
  417. On the "three-in-one" approach in family planning in rural China.
  418. On the pill: a social history of oral contraceptives in America, 1950-1970.
  419. On-the-job training for family planning service providers.
  420. An open randomized comparative study of an oral contraceptive containing ethinyl estradiol and cyproterone acetate with and without the GnRH analogue goserelin in the long-term treatment of hirsutism.
  421. Operational research for an effective information and training approach for surgical contraception knowledge and attitude in Turkey.
  422. An operations research to determine the accuracy of the family planning (FP) and maternal-and-child health (MCH) reports of the five health areas in Cebu City.
  423. Oral contraception -- making an informed choice.
  424. Oral contraception and adolescent women with insulin-dependent diabetes mellitus: risks, benefits, and implications for practice.
  425. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis.
  426. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
  427. Oral contraceptive pill method failures [letter]
  428. Oral contraceptive pills and the risk of venous thromboembolism.
  429. Oral contraceptive switching patterns in the United Kingdom: an important potential confounding variable in studies of venous thromboembolism.
  430. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
  431. Oral contraceptive use and breast cancer risk in areas with different incidence. A case-control study among young women.
  432. Oral contraceptive use and coronary and cardiovascular risk.
  433. Oral contraceptive use and smoking habits in Spanish women. [Consumo de anticonceptivos y habito tabaquico en las mujeres espanolas.]
  434. Oral contraceptives alter circadian rhythm parameters of cortisol, melatonin, blood pressure, heart rate, skin blood flow, transepidermal water loss, and skin amino acids of healthy young women.
  435. Oral contraceptives and breast cancer -- resolution emerges [editorial]
  436. Oral contraceptives and breast cancer.
  437. Oral contraceptives and breast cancer.
  438. Oral contraceptives and cancer. A review of the evidence.
  439. Oral contraceptives and cervical cancer -- further findings from the Oxford Family Planning Association contraceptive study.
  440. Oral contraceptives and cholesterol.
  441. Oral contraceptives and hormone replacement therapy may protect against colorectal cancer.
  442. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix.
  443. Oral contraceptives and mortality from venous thromboembolism [letter]
  444. Oral contraceptives and mortality from venous thromboembolism [letter]
  445. Oral contraceptives and mortality from venous thromboembolism [letter]
  446. Oral contraceptives and mortality from venous thromboembolism. Author's reply [letter]
  447. Oral contraceptives and mortality from venous thromboembolism. Authors' reply [letter]
  448. Oral contraceptives and primary liver cancer: temporal trends in three countries.
  449. Oral contraceptives and risk of breast cancer. A historical prospective case-control study.
  450. Oral contraceptives and risk of disease.
  451. Oral contraceptives and screening for factor V Lieden [letter]
  452. Oral contraceptives and sexuality in university women.
  453. Oral contraceptives and the risk of DVT.
  454. Oral contraceptives and thrombotic diseases: impact of new epidemiological studies [editorial]
  455. Oral contraceptives and thrombotic diseases: impact of new epidemiological studies [letter]
  456. Oral contraceptives and venous thromboembolism.
  457. Oral contraceptives and venous thromboembolism.
  458. Oral contraceptives and venous thromboembolism: consensus conference statement.
  459. Oral contraceptives and venous thromboembolism: should epidemiologic associations drive clinical decision making? [editorial]
  460. Oral contraceptives are a risk factor for cerebral vein thrombosis [letter]
  461. Oral contraceptives are safe, very effective.
  462. Oral contraceptives do not raise risk of heart disease.
  463. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
  464. Oral contraceptives in the treatment of Darier-White disease -- a case report and review of the literature.
  465. Oral contraceptives in women with systemic lupus erythematosus.
  466. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease [letter]
  467. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Authors' reply [letter]
  468. Oral contraceptives.
  469. Oral contraceptives: exploring the benefits, dispelling the myths.
  470. Our bodies, our risk. Dilemmas in contraceptive information.
  471. The outcome of replacing an intrauterine contraceptive device at the time of large loop excision of the transformation zone.
  472. Ovarian activity during regular oral contraceptive use.
  473. Overcoming cultural constraints to family planning and reproductive health in Ghana.
  474. Overview of potential POLICY Project contributions to overcome strategic challenges and foster long-term sustainability in the Indonesian Family Planning Program.
  475. p53 mutations in hepatocellular carcinoma related to oral contraceptive use.
  476. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
  477. Peliosis hepatis associated with oral contraceptive use.
  478. Penetration of the bladder by a perforating intrauterine contraceptive device: a sonographic diagnosis.
  479. The perceived quality of service at a family planning clinic: a marketing focus. [La calidad percibida del servicio de un centro de planificacion familiar: un enfoque de marketing.]
  480. Perceptions and realities: How safe is the pill? The role of the media, healthcare providers, and the pharmaceutical industry in shaping American women's perceptions about birth control. Q and A.
  481. Perceptions of health providers, family planning, and contraceptives in Zambia: "Smoke that Thunders". Zambia Family Planning Services Project Image Study report. Draft.
  482. Perceptions of population policy, development, and family planning programs in northern Nigeria.
  483. Performance indicators: moving from a demographically-oriented family planning program to a client-centered reproductive health paradigm.
  484. The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days.
  485. Pharmacokinetics of depot medroxyprogesterone acetate contraception.
  486. The pill, and then? Two generations cope with birth control. [La pilule, et apres? Deux generations face au controle des naissances.]
  487. Pioneers in family planning: Zahia Marzouk (1906-1988)
  488. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
  489. The Planned Parenthood Association.
  490. Plasma resistance to activated protein C: an important link between venous thromboembolism and combined oral contraceptives -- a short review.
  491. The politics and practice of contraceptive use in South Africa: a multilevel analysis of the demographic legacy of apartheid.
  492. Popular soap opera helps raise contraceptive use. Tanzania.
  493. Population and family planning in Tibet.
  494. Population and family planning reviewed (1991-1995)
  495. Posing a hidden political threat. Pakistan. No attempt has been made at the national level to evolve a religious consensus on the subject of family planning.
  496. Post-partum contraception.
  497. Postabortion contraceptive services scarce in Turkey.
  498. Postpartum family planning and health in Istanbul: bringing fathers into the picture (1994-1996). Research summary.
  499. Postpartum family planning and health needs of women of low income in Istanbul (1991-92). Research summary.
  500. Potential constraints to and prospects of improving quality of care in family planning programmes in developing countries.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.